The present invention relates to pharmaceutical compositions having an
effect on the proliferation of NK cells, to a method for specifically
stimulating the proliferation of NK cell and to the use of same in the
manufacture of a drug for the antitumoral prevention, palliation, and
therapy of e.g., melanoma, hepatocarcinoma or lung adenocarcinoma and for
anti-microbial prevention, palliation and therapy.